Tissue factor (TF), a transmembrane glycoprotein, functions as an essential activator of the serine protease factor Vlla. This enzymatic complex is considered to be the principal initiator of in vivo coagulation. Recent studies emphasize the role of the TF/Vlla complex in a number of pathophysiologi
Inhibition of the tissue factor/factor VIIa complex — Lead optimisation using combinatorial chemistry
✍ Scribed by Patrick Roussel; Mark Bradley; Peter Kane; Christine Bailey; Ruth Arnold; Andrew Cross
- Book ID
- 104209378
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- French
- Weight
- 754 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0040-4020
No coin nor oath required. For personal study only.
✦ Synopsis
Following a high throughput screen (HTS) for the inhibition of the tissue factor/factor Vlla complex and the identification of a number of original hits a lead optimisation programme was initiated to improve their potency. This necessitated the development of an amidine based linker which allowed the generation of a library of amidinonaphthols prepared both by multiple parallel synthesis (MPS) and split and mix methods. The most active compound had an ICso of 411M some 10x more potent than the original lead compound.
📜 SIMILAR VOLUMES
The characteristics of a phospholipid surface are of major importance in the activation of factor X in the presence of tissue factor-factor VIIa (TF-VIIa) complex. A possible tool which provides a measure of the surface corrugation and roughness is the fractal dimension analysis. This paper uses the
The effect of shear stress on the ability of tissue factorfactor VIIa complex to activate factor X in a continuous flow reactor was studied. Tissue factor immobilized in a phospholipid bilayer on the inner surface of a capillary tube was exposed to a perfusate containing factors VIIa and X flowing a